title: Triglyceride-lowering therapy for hypertriglyceridemia. Literature review
metadata.name: dc.contributor.author
metadata.value: Shomin, Alexandr V.
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Serezhina, Elena K.
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Obrezan, Andrey G.
metadata.lang: -
metadata.name: dc.date.accessioned
metadata.value: 2024-11-22T17:47:13Z
metadata.lang: -
metadata.name: dc.date.available
metadata.value: 2024-11-22T17:47:13Z
metadata.lang: -
metadata.name: dc.date.issued
metadata.value: 2024-06
metadata.lang: -
metadata.name: dc.identifier.citation
metadata.value: Shomin A. V., Serezhina E. K., Obrezan A. G. Triglyceride-lowering therapy for hypertriglyceridemia. Literature review. Vestnik of Saint Petersburg University. Medicine, 2024, vol. 19, issue 2, pp. 118–127. https://doi.org/10.21638/spbu11.2024.202 (In Russian)
metadata.lang: en_GB
metadata.name: dc.identifier.other
metadata.value: https://doi.org/10.21638/spbu11.2024.202
metadata.lang: -
metadata.name: dc.identifier.uri
metadata.value: http://hdl.handle.net/11701/47989
metadata.lang: -
metadata.name: dc.description.abstract
metadata.value: Hypertriglyceridemia is a polyetiological lipid metabolism disorder, which is characterized by
  an increased residual risk of atherosclerosis-associated cardiovascular system pathology. This
  literature review presents current data on aspects of drug therapy for this dyslipidemia, which
  allows for a more comprehensive approach to the treatment strategies. This analysis is based
  on modern sources, the materials of which were published from 2010 to 2024 in Russian and
  English in international scientific online libraries. The article discusses the main drugs groups
  to consider the phenomenon under consideration: niacin, fibrates, omega-3 polyunsaturated
  fatty acids. The analysis of research results indicates that the prescription of drugs aimed at
  reducing triglyceride levels is a promising direction in advanced lipidology. The most promising
  drugs at the moment are omega-3 polyunsaturated fatty acids, fibric acid agents, and evinacumab.
  The pharmacological correction features of high triglyceride levels and promising
  therapeutic directions are highlighted.
metadata.lang: en_GB
metadata.name: dc.language.iso
metadata.value: ru
metadata.lang: en_GB
metadata.name: dc.publisher
metadata.value: St Petersburg State University
metadata.lang: en_GB
metadata.name: dc.relation.ispartofseries
metadata.value: Vestnik of St Petersburg University. Medicine;Volume 19; Issue 2
metadata.lang: -
metadata.name: dc.subject
metadata.value: hypertriglyceridemia
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: dyslipidemia
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: triglycerides
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: lipidology
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: statins
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: fibrates
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: niacin
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: omega-3 polyunsaturated fatty acids
metadata.lang: en_GB
metadata.name: dc.title
metadata.value: Triglyceride-lowering therapy for hypertriglyceridemia. Literature review
metadata.lang: en_GB
metadata.name: dc.type
metadata.value: Article
metadata.lang: en_GB
resources.filename: 11-2-2024+для+сайта_14-23.pdf
resources.url: https://dspace.spbu.ru/bitstream/11701/47989/1/11-2-2024%2b%d0%b4%d0%bb%d1%8f%2b%d1%81%d0%b0%d0%b9%d1%82%d0%b0_14-23.pdf
resources.format: Adobe PDF
resources.size: 622,86 kB